Clinical Trials in New York

Showing 2001-2020 of 19,464 trials

Safety, Pharmacokinetics (PK), and Efficacy of ONC-783 in Advanced Solid Tumors

NCT07408258

ONC-783-001 is a Phase I open label, dose-escalation study for evaluating the safety, pharmacokinetics (PK) and efficacy of ONC-783 as a single agent in patients with advanced/metastatic solid tumors, focusing on colorectal cancer, ovarian cancer, pancreatic cancer, or breast cancer.

Advanced Solid Tumor

OncoC4, Inc.20 participantsStarted Jun 2026

New York, New York, United States • Houston, Texas, United States

Active Not Recruiting< 1 mile

Comparing Patients' and Surgeons' Expectations of Lumbar Spine Surgery

NCT02257554

The goals of this study are to assess concordance between the patient-surgeon pair regarding expectations of lumbar spine surgery.

Lumbar Spine Surgery

Hospital for Special Surgery, New York437 participantsStarted Sep 2014

New York, New York, United States

Active Not RecruitingPhase 2< 1 mile

A Study of Tucatinib Given Before Surgery to People With HER2+ Cancers That Have Spread to the Brain

NCT05892068

The purpose of this study to see how the brain absorbs, distributes, and gets rid of tucatinib in people who have HER2+ cancers (breast cancer, NSCLC, CRC, or GEC) that have spread to the brain, and to learn more about how cancer cells develop resistance to treatment. The researchers will do research tests to look for genetic differences between HER2+ breast cancer that has spread to the brain and progressed during treatment with tucatinib and cancers that are being treated with tucatinib for the first time.

Metastatic Breast Cancer

Memorial Sloan Kettering Cancer Center9 participantsStarted May 2023

Basking Ridge, New Jersey, United States • Middletown, New Jersey, United States • Montvale, New Jersey, United States +4 more locations

Safety, Pharmacokinetics (PK), and Efficacy of ONC-783 in Advanced Solid Tumors

Comparing Patients' and Surgeons' Expectations of Lumbar Spine Surgery

A Study of Tucatinib Given Before Surgery to People With HER2+ Cancers That Have Spread to the Brain

Find Trials by Condition in New York

REFLECT Scoliosis System Post Approval Study

A Social Network Approach to Improve HIV Prevention and Substance Use Treatment For People Who Use Drugs

PRP in ACLR to Prevent PTOA

Vascular Endothelial Dysfunction in Sleep Apnea

REdo tranScatheter Aortic Valve Replacement for Transcatheter aOrtic Valve failuRE

Study of Bitopertin in Participants With EPP or XLP (APOLLO)

A Trial to Evaluate the Efficacy and Safety of Different Doses of LEO 138559 in Adults With Moderate-to-severe Atopic Dermatitis

Biventricular Remodeling in Transcatheter Tricuspid Valve Replacement - Acute Hemodynamic Instability Study

Observational Study of LUMRYZ in Narcolepsy

Safety and Efficacy of BNT327, an Investigational Therapy in Combination With Chemotherapy for Patients With Untreated Small-cell Lung Cancer

Acceptance and Commitment Therapy to Improve Social Support for Veterans With PTSD

AMG 410 Alone and in Combination With Other Agents in Participants With KRAS Altered Advanced or Metastatic Solid Tumors

Compassionate Use of Concizumab if You Have Haemophilia

Study to Assess Safety, Efficacy and Persistence of ACE1831, in Subjects With IgG4-Related Disease

Safety, Tolerability, PK, and PD Study of PGN-EDODM1 in Participants With Myotonic Dystrophy Type 1

A Study of TAK-360 in Adults With Narcolepsy Without Cataplexy (NT2)

SPI-62 as a Treatment for Hypercortisolism Related to a Benign Adrenal Tumor